Spero Therapeutics Cash Flow Statement (2016-2026) | SPRO

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-18.46M-22.43M-27.43M-30.14M-25.97M-11.47M27.49M-13.26M-11.91M-3.19M55.11M-12.65M-17.86M-17.70M-24.07M-13.87M-1.70M-7.38M31.52M-7.20M
Share-based Compensation (Quarter)
2.16M2.33M2.93M3.20M1.32M2.11M2.50M2.17M1.86M1.91M2.00M2.02M2.11M2.15M1.50M1.56M0.71M1.05M1.01M1.11M
Deferred Taxes (Quarter)
Gains from Investment Securities (Quarter)
4.58M1.51M4.89M5.78M4.62M0.14M0.10M4.00M3.73M1.11M2.21M0.04M0.04M0.04M2.81M0.23M0.41M2.40M
Asset Writedowns and Impairment (Quarter)
5.31M0.60M
Non-cash Items (Quarter)
2.26M33.21M24.26M3.95M2.96M0.00M0.00M0.00M0.00M0.00M0.00M2.49M2.54M2.62M105.97M20.88M0.06M0.18M
Cash from Operations (Quarter)
-16.57M-4.95M-27.35M-28.22M-23.03M-0.96M44.48M-12.85M-18.56M15.91M-17.49M5.94M-18.74M12.76M-23.40M-4.00M-17.69M17.42M-8.35M15.86M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.06M-0.07M-0.05M-0.02M0.01M
Depreciation & Amortization (CF) (Quarter)
0.15M0.15M0.19M0.19M0.29M0.26M0.13M0.11M0.11M0.11M0.04M0.00M
Change in Working Capital
Change in Receivables (Quarter)
-6.70M0.39M0.04M-0.66M-0.39M-0.62M0.13M0.78M0.22M0.90M-1.44M3.47M-0.28M-2.04M0.39M-2.42M1.79M-0.87M-1.56M0.02M
Change in Account Payables (Quarter)
-2.21M1.53M-2.06M3.68M-3.07M0.87M-1.97M-0.03M0.73M-0.21M0.28M1.69M-0.37M3.39M1.22M-5.54M-0.98M0.61M-0.70M-0.48M
Change in Accured Expenses (Quarter)
-3.94M0.13M5.29M-5.29M-0.55M-0.42M0.88M-0.11M-3.26M0.96M-0.01M-1.18M4.63M5.32M2.40M-9.54M-1.46M1.08M-2.23M-2.44M
Change in Taxes (Quarter)
-1.82M-0.29M0.08M-0.01M0.22M-0.22M
Other Working Capital Changes (Quarter)
0.18M-2.74M3.08M-0.28M-0.62M4.43M-3.57M0.16M-0.66M-0.32M-0.29M-0.05M-0.56M0.53M-1.17M-0.34M0.34M-0.01M-1.39M-0.42M
Investing Activities
Capital Expenditures (Quarter)
-0.04M
Change in Acquisitions & Divestments (Quarter)
20.50M18.05M7.00M10.91M49.87M
Cash from Investing Activities (Quarter)
10.92M17.02M-23.27M-16.06M50.00M-0.13M
Financing Activities
Other financing activities (Quarter)
0.11M0.10M-0.16M
Cash from Financing Activities (Quarter)
0.17M29.22M50.35M3.81M-53.68M6.13M14.18M0.22M0.00M
Dividend Payments
Dividends Paid - Common (Quarter)
Additional items
Change in Cash (Quarter)
-5.48M41.30M-0.28M-40.47M-26.71M5.04M58.66M-12.85M-18.56M16.14M-17.49M5.94M-18.74M12.76M-23.40M-4.00M-17.69M17.42M-8.35M15.86M
Free Cash Flow (Quarter)
-16.57M-4.95M-27.31M-28.22M-23.03M-0.96M44.48M-12.85M-18.56M15.91M-17.49M5.94M-18.74M12.76M-23.40M-4.00M-17.69M17.42M-8.35M15.86M
Net Cash Flow (Quarter)
-5.48M41.30M-0.28M-40.47M-26.71M5.04M58.66M-12.85M-18.56M16.14M-17.49M5.94M-18.74M12.76M-23.40M-4.00M-17.69M17.42M-8.35M15.86M